bioRxivMolecular BiologyPreprint
Interrogating the Mechanisms of Cas9-mediated Allele Conversion
Joss B. MurrayiD, Emma Collins, Lisa Lonetti, Lucia NicosiaiD, Tadhg CrowleyiD, Ciaran M. LeeiD, Patrick T. HarrisoniD
Abstract
Allele conversion describes a process where a heterozygous variant is made homozygous. Recently, it has been shown that allele conversion can be triggered by DNA damage at the heterozygous site. This process has the potential to repair pathogenic heterozygous mutations; however, the efficiency is low. Here, we endeavoured to understand the mechanism underlying allele conversion, ultimately to raise allele conversion efficiency to functionally relevant levels. To test this, we developed a Compound Heterozygous Allele Conversion Reporter (CHACR) cell line. This line comprises knocked-in fluorescent protein encoding genes, with heterozygous inactivating mutations resulting in different fluorescence profiles from each allele. These mutations create protospacer adjacent motifs (PAM) for Cas9 recognition, where allele-specific gRNAs (AS-gRNAs) target the heterozygous mutations. We showed that applying these AS-gRNAs with either Cas9 nuclease or Cas9(D10A) nickase can recover mCherry fluorescence. Sorting and sequencing these fluorescent cells revealed wild-type sequences, suggesting allele conversion repaired the mutation using the homologous allele as a template. Allele conversion can also be triggered using an adenine base editor with an AS-gRNA, and this allele conversion mechanism can be manipulated by inhibiting DNA-PKcs or overexpressing RAD51. This work introduces a model for measuring allele conversion, and modifiers of this mechanism.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Allele-specific correction of ATAD3A pathogenic variants via template-free CRISPR-Cas9 editing and gene conversion
Taejeong Bae, Yohan Park, … Wan Hee Yoon·bioRxiv·Oct 23, 2025
- Altered DNA repair pathway engagement by engineered CRISPR-Cas9 nucleases
V. P. Chauhan, P. A. Sharp, R. Langer·bioRxiv·Mar 10, 2022
- Heterochromatin delays CRISPR-Cas9 mutagenesis but does not influence repair outcome
Kallimasioti Pazi, Keerthi T. Chathoth, … Andrew J. Wood·PLoS BiologyPeer-reviewed·Dec 12, 2018
- Decorating chromatin for enhanced genome editing using CRISPR-Cas9
Evelyn Chen, Enrique Lin-Shiao, … Jennifer A. Doudna·Proceedings of the National Academy of SciencesPeer-reviewed·Dec 2, 2022
- Efficient repair of human homozygous genetic mutation by CRISPR/Cas9 mediated interlocus gene conversion
Fei Yang, Jingtao Pang, … Yuxuan Wu·bioRxiv·Sep 5, 2022
- Repair of leukemia-associated single nucleotide variants via interallelic gene conversion
Alexander James Silver, Donovan J Brown, … Michael R Savona·bioRxiv·Apr 16, 2024